1-7 of 7
Paolo G. Gobbi
Close
Sort by
Journal Articles

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi

Francesco Merli, MD, Stefano Luminari, MD, Caterina Mammi, PhD, Nicola Cascavilla, MD, Alessia Bari, MD, Caterina Stelitano, MD, Renato Scalone, MD, Luca Baldini, Prof, Francesco Angrilli, MD, Giuseppe Polimeno, MD, Paolo G Gobbi, Prof, Giulia Cervetti, MD, Fiorella Ilariucci, MD, Alessia Ruffini, Luigi Marcheselli, Massimo Federico, MD
Journal: Blood
Blood (2014) 124 (21): 499.
https://doi.org/10.1182/blood.V124.21.499.499
Published: 2014
Journal Articles

Are Absolute Monocyte Count and The Lymphocyte-Monocyte Ratio (LMR) Valid Prognostic Factors In Classical Hodgkin Lymphoma? An Evaluation Based On Data From 1079 Patients

Stefano Sacchi, MD, Alessia Bari, MD, Tamar Tadmor, MD, Luigi Marcheselli, MS, Samantha Pozzi, MD, Eliana Valentina Liardo, MD, Angela Ferrari, MD, Caterina Stelitano, Paolo G Gobbi, Prof, Luca Baldini, Daniele Vallisa, MD, Emilio Iannitto, MD, Aaron Polliack, MD, Massimo Federico
Journal: Blood
Blood (2013) 122 (21): 1754.
https://doi.org/10.1182/blood.V122.21.1754.1754
Published: 2013
Journal Articles

How I treat enteropathy-associated T-cell lymphoma

Antonio Di Sabatino, Federico Biagi, Paolo G. Gobbi, Gino R. Corazza
Journal: Blood
Blood (2012) 119 (11): 2458–2468.
https://doi.org/10.1182/blood-2011-10-385559
Published: 2012
Journal Articles

FDG-PET and Hodgkin Lymphoma: Are We Ready for a Functional Tumor Volume Definition?

Francesco Merli, MD, Stefano Luminari, MD, Chiara Coriani, MD, Paolo G Gobbi, Prof, Federica Fioroni, Dr, Isabella Capodanno, MD, Alessandro Fraternali, MD, Caterina Mammi, PhD, Annibale Versari, MD
Journal: Blood
Blood (2011) 118 (21): 5187.
https://doi.org/10.1182/blood.V118.21.5187.5187
Published: 2011
Journal Articles

Response-Based Chemotherapy and Involved Field Radiation for Intermediate Stage Hodgkin Disease. A GISL/NHLSG Trial.

Emilio Iannitto, MD, Viviana Minardi, MD, Paolo G. Gobbi, MD, Giuseppina Calvaruso, MD, Caterina Stelitano, MD, Luca Baldini, MD, Francesco Merli, MD, Mario Petrini, MD, Luigi Marcheselli, Ph.D, Caterina Mammi, Ph.D, Stefano De Cantis, MD, Vincenzo Abbadessa, MD, Massimo Federico, MD
Journal: Blood
Blood (2006) 108 (11): 2475.
https://doi.org/10.1182/blood.V108.11.2475.2475
Published: 2006
Journal Articles

Early Response to a Short Course of Induction Chemotherapy Overcomes the Prognostic Role of IPI in Patients with Aggressive NHL. Preliminary Results of the GISL LA05 Trial.

Nicola Di Renzo, MD, Stefano Luminari, MD, Antonella Montanini, BSc,PhD, Mario Petrini, MD, Maura Brugiatelli, MD, Paolo G. Gobbi, MD, Caterina Stelitano, MD, Francesco Angrilli, MD, Maurizio Musso, MD, Luca Baldini, MD, Patrizio Mazza, MD, Elsa Pennese, MD, Massimo Federico, MD
Journal: Blood
Blood (2006) 108 (11): 2434.
https://doi.org/10.1182/blood.V108.11.2434.2434
Published: 2006
Journal Articles

Long-Term Results From MOPPEBVCAD Chemotherapy With Optional Limited Radiotherapy in Advanced Hodgkin's Disease

Paolo G. Gobbi, Carla Pieresca, Maria L. Ghirardelli, Nicola DiRenzo, Massimo Federico, Francesco Merli, Emilio Iannitto, Vincenzo Pitini, Giovanni Grignani, Amedea Donelli, Mario Carotenuto, Vittorio Silingardi, Edoardo Ascari, the Gruppo Italiano per lo Studio dei Linfomi
Journal: Blood
Blood (1998) 91 (8): 2704–2712.
https://doi.org/10.1182/blood.V91.8.2704.2704_2704_2712
Published: 1998